IN Brief:
- Framptons has returned to profit after restructuring and renewed investment in plant and machinery.
- A third Tetra Edge A3 line is due to be installed by the end of 2026, adding 40m units of capacity.
- The investment strengthens UK aseptic beverage manufacturing capacity as plant-based drink formats continue to mature.
Framptons has returned to profit after restructuring and investment in plant and machinery, with further capacity due to come on stream through a third Tetra Edge A3 line by the end of 2026.
The Somerset-based manufacturer reported a return to the black following operational changes and a £2.3m investment in plant and machinery to improve throughput and reliability. The additional Tetra Edge A3 line is expected to increase production capacity by 40m units, strengthening the company’s position in plant-based drinks and wider aseptic beverage manufacturing.
Framptons operates as an independent UK plant-based drinks manufacturer, producing oat, soya, and coconut drinks across conventional, organic, gluten-free, and foodservice formats. The company also works in contract manufacturing, with Tetra Brik Aseptic Edge formats forming part of its pack offer.
The Tetra Edge A3 investment reflects the way plant-based beverages are now competing on manufacturing reliability as much as category growth. The early phase of the market was driven by product launches, brand positioning, and rapid retailer expansion. The next phase depends more heavily on cost control, pack efficiency, consistency, and the ability to run multiple recipes and formats without excessive downtime.
Aseptic production gives manufacturers access to ambient shelf-life formats that can reduce chilled-chain pressure and support broader distribution. It also places high demands on line hygiene, filling accuracy, pack integrity, sterilisation, cleaning, and validation. Plant-based drinks add further technical demands, including ingredient suspension, viscosity control, protein stability, heat treatment, flavour consistency, and sediment management.
Framptons’ financial recovery shows how closely factory capability and commercial performance can be linked. Plant investment that improves throughput and reliability can reduce unit costs, improve service levels, and create headroom for customer growth. In beverage manufacturing, where customer contracts often depend on consistent supply and tight scheduling, line reliability quickly becomes a commercial asset.
The plant-based drinks sector has also become more disciplined. Growth remains important, but the category is no longer treated as a guaranteed expansion story. Brands and manufacturers are dealing with price sensitivity, dairy comparison, retail space pressure, ingredient costs, and regulatory scrutiny around dairy terminology. The same category tension is visible across dairy and dairy-alternative production, where lactoferrin investment, dairy-free flavour systems, and plant-based capacity are all competing for capital and technical attention.
Additional aseptic capacity can give Framptons more flexibility to serve private-label, branded, foodservice, and contract manufacturing demand. Retailers and foodservice operators still need reliable supply of oat, soya, and coconut drinks, but they are likely to reward manufacturers that can combine quality, pack efficiency, and responsive production.
The Tetra Edge format also has logistics advantages. Framptons has highlighted the pallet efficiency of the 1L Tetra Brik Aseptic Edge format, with the ability to fit more packages per pallet than some standard alternatives. In beverage supply chains, pack geometry affects transport efficiency, warehousing, handling, and retailer replenishment. Small differences in pallet density can influence cost and emissions at scale.
The company’s investment comes as UK food and drink manufacturers continue to make selective capital decisions under pressure from labour, energy, packaging, and customer pricing. Projects that increase resilience and reliability are easier to justify than speculative capacity alone. A line that adds volume while improving pack performance and operational flexibility can support both growth and margin recovery.
Plant-based drinks must now deliver consistent taste, predictable performance in coffee and foodservice applications, ambient stability, and credible nutrition, while remaining competitive on price. Behind those demands sits a highly controlled processing system. Framptons’ latest investment suggests the category’s next stage will be shaped less by launch volume and more by the strength of the production base behind it.
